Literature DB >> 112920

In vitro comparison of rosamicin and erythromycin against urinary tract pathogens.

T C Eickhoff, J M Ehret.   

Abstract

The in vitro activity of rosamicin and erythromycin was compared at various pH values against 311 strains of bacteria representing common urinary tract pathogens. Alkalinization of the media consistently and significantly increased the antibacterial activity of rosamicin against all of the organisms tested. This was also true for erythromycin except when tested against strains of Proteus. At pH 8, rosamicin was two- to sixfold more active than erythromycin against Enterobacteriaceae. The activity of both antibiotics against Pseudomonas aeruginosa was very similar when tested at pH 8. Erythromycin was twice as active as rosamicin at pH 8 against group D streptococci. The activity of both antibiotics was bacteriostatic and inoculum size dependent, regardless of the organism tested or the pH of the test media. The greater activity of rosamicin against Enterobacteriaceae warrants clinical investigation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 112920      PMCID: PMC352790          DOI: 10.1128/AAC.16.1.69

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Sensitivity of E. coli, Ps. aeruginosa and B. proteus to erythromycin in various pH culture media.

Authors:  Z ZAGAR
Journal:  Chemotherapia (Basel)       Date:  1963

2.  The antibacterial action of erythromycin.

Authors:  T H HAIGHT; M FINLAND
Journal:  Proc Soc Exp Biol Med       Date:  1952-10

3.  Erythromycin and alkalinisation of urine in the treatment of urinary-tract infections due to gram-negative bacilli.

Authors:  S H Zinner; L D Sabath; J I Casey; M Finland
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

4.  Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.

Authors:  J A Waitz; C G Drube; E L Moss; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1972-11       Impact factor: 2.649

5.  Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.

Authors:  C C Crowe; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

6.  A new Micromonospora-produced macrolide antibiotic, rosamicin.

Authors:  G H Wagman; J A Waitz; J Marquez; A Murawaski; E M Oden; R T Testa; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1972-11       Impact factor: 2.649

7.  Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.

Authors:  L D Sabath; D A Gerstein; P B Loder; M Finland
Journal:  J Lab Clin Med       Date:  1968-12

8.  Effectiveness of erythromycin plus alkalinization and of nitrofurantoin in the treatment of urinary tract infections.

Authors:  J Klastersky; L Debusscher; D Daneau
Journal:  Curr Ther Res Clin Exp       Date:  1971-07

9.  Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli.

Authors:  V Lorian; L D Sabath
Journal:  Appl Microbiol       Date:  1970-11

10.  Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria.

Authors:  L D Sabath; V Lorian; D Gerstein; P B Loder; M Finland
Journal:  Appl Microbiol       Date:  1968-09
  10 in total
  1 in total

1.  Epidemiology of intestinal colonization by members of the family Enterobacteriaceae highly resistant to erythromycin in a hematology-oncology unit.

Authors:  A Andremont; H Sancho-Garnier; C Tancrede
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.